Consumer Retailing Healthcare Sector

Aytu BioPharma

Market Cap: US$12.5m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

Bolt Biotherapeutics

Market Cap: US$12.5m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

Bright Green

Market Cap: US$12.4m

Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.

CS Diagnostics

Market Cap: US$12.4m

Manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally.

Vivos Therapeutics

Market Cap: US$12.3m

Operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Marker Therapeutics

Market Cap: US$12.1m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

Induction Healthcare Group

Market Cap: UK£8.9m

Provides software to healthcare professionals in the United Kingdom.

Meihua International Medical Technologies

Market Cap: US$12.1m

Meihua International Medical Technologies Co., Ltd.

IN8bio

Market Cap: US$12.1m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.

Cosmos Health

Market Cap: US$12.0m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.

BioRestorative Therapies

Market Cap: US$12.0m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States and Canada.

Abpro Holdings

Market Cap: US$11.9m

A biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology.

Resonance Health

Market Cap: AU$18.4m

A healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa.

ImExHS

Market Cap: AU$18.2m

Offers cloud-based medical imaging solutions in Australia and internationally.

Welsis

Market Cap: US$11.8m

A development stage startup company, engages in the provision of online psychological help services.

Evaxion

Market Cap: US$11.8m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

WORK Medical Technology Group

Market Cap: US$11.7m

Manufactures and sells medical consumables in the People’s Republic of China and internationally.

Scienture Holdings

Market Cap: US$11.7m

Operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

Hemostemix

Market Cap: CA$16.0m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Lotus Pharmaceuticals

Market Cap: US$11.6m

Does not have significant operations.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Cellectar Biosciences

Market Cap: US$11.6m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

Aesthetic Medical International Holdings Group

Market Cap: US$11.6m

Provides aesthetic medical services in the People’s Republic of China and Singapore.

MSP Recovery

Market Cap: US$11.5m

MSP Recovery, Inc., doing business as LifeWallet, operates as a healthcare recovery and data analytics company in the United States and Puerto Rico.

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.

COSCIENS Biopharma

Market Cap: CA$15.6m

A life science company, engages in developing and commercializing products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Columbia, the United Kingdom, and internationally.

Bionano Genomics

Market Cap: US$11.3m

Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

SOL Global Investments

Market Cap: CA$15.5m

A private equity firm specializing in growth capital to small and mid-sized businesses.

Rhythm Biosciences

Market Cap: AU$17.3m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

SeaStar Medical Holding

Market Cap: US$11.2m

A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

genedrive

Market Cap: UK£8.2m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Hoth Therapeutics

Market Cap: US$11.1m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

BetterLife Pharma

Market Cap: US$11.0m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Aspire Biopharma Holdings

Market Cap: US$11.0m

An early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States.

Neuphoria Therapeutics

Market Cap: US$10.9m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.